Results 11 to 20 of about 6,010 (176)

Metaheuristics for pharmacometrics [PDF]

open access: yesCPT: Pharmacometrics & Systems Pharmacology, 2021
Metaheuristics is a powerful optimization tool that is increasingly used across disciplines to tackle general purpose optimization problems. Nature‐inspired metaheuristic algorithms is a subclass of metaheuristic algorithms and have been shown to be ...
Seongho Kim   +4 more
doaj   +4 more sources

Use of Modeling and Simulation to Inform the Development of Monoclonal Antibodies to Treat Moderate‐to‐Severe Asthma: A Retrospective Review of EMA Centralized Procedure From 2014 to 2024

open access: yesCPT: Pharmacometrics & Systems Pharmacology
We present here a repository of key regulatory questions answered in centralized procedures and evaluate the place of modeling and simulation in marketing authorization process for biologics approved for the treatment of moderate‐to‐severe asthma from ...
Hélène Haguet   +2 more
doaj   +2 more sources

Pharmacometrics: A New Era of Pharmacotherapy and Drug Development in Low- and Middle-Income Countries

open access: yesAdvances in Pharmacological and Pharmaceutical Sciences, 2023
Pharmacotherapy, in many cases, is practiced at a suboptimal level of performance in low- and middle-income countries (LMICs) although stupendous amounts of data are available regularly.
Muhammad Usman   +5 more
doaj   +1 more source

Pharmacometrics approaches and its applications in diabetes: An overview

open access: yesJournal of Pharmacy and Bioallied Sciences, 2021
Type 2 diabetes mellitus is the most prevalent and progressive in nature. As the time progress, the multifaceted complications and comorbidities associated to diabetes worsen in the form of macrovascular or microvascular or both. Pharmacometrics modeling
Sohail Aziz   +3 more
doaj   +1 more source

Variable or variate? A conundrum in pharmacometrics exposure–response models

open access: yesCPT: Pharmacometrics & Systems Pharmacology, 2023
Key elements of scientific writing—consistency and clarity—can be compromised in case of inaccurate use of methodological terms, especially in complex and multidisciplinary scientific fields.
Ana‐Marija Grisic   +3 more
doaj   +1 more source

Pharmacometrics in tuberculosis: progress and opportunities [PDF]

open access: yesInternational Journal of Antimicrobial Agents, 2022
Tuberculosis (TB) remains one of the leading causes of death by a communicable agent, infecting up to one-quarter of the world's population, predominantly in disadvantaged communities. Pharmacometrics employ quantitative mathematical models to describe the relationships between pharmacokinetics and pharmacodynamics, and to predict drug doses, exposures
Wilkins, J.J.   +6 more
openaire   +3 more sources

Exposure‐response modeling for extrapolation from adult to pediatric patients who differ with respect to prognostic factors: Application to everolimus

open access: yesCPT: Pharmacometrics & Systems Pharmacology, 2021
Pediatric extrapolation is essential for bringing treatments to the pediatric population, especially for indications where the recruitment of pediatric patients into clinical trials is difficult and where fully powered trials are impossible.
Thomas Dumortier   +2 more
doaj   +1 more source

A generic framework for the physiologically‐based pharmacokinetic platform qualification of PK‐Sim and its application to predicting cytochrome P450 3A4–mediated drug–drug interactions

open access: yesCPT: Pharmacometrics & Systems Pharmacology, 2021
The success of applications of physiologically‐based pharmacokinetic (PBPK) modeling in drug development and drug labeling has triggered regulatory agencies to demand rigorous demonstration of the predictive capability of the specific PBPK platform for a
Sebastian Frechen   +7 more
doaj   +1 more source

Pharmacometric Characterization of Dabigatran Hemodialysis [PDF]

open access: yesClinical Pharmacokinetics, 2013
Hemodialysis has been shown to be a useful method of decreasing dabigatran plasma levels in situations that require rapid elimination of this thrombin inhibitor. However, there is currently no clinical recommendation for the accelerated/optimized elimination of dabigatran via hemodialysis (e.g., flow rates, filter type, duration of dialysis).The ...
Liesenfeld, Karl-Heinz   +5 more
openaire   +2 more sources

Physiologically Based Pharmacokinetic Modeling of Monoclonal Antibodies in Pediatric Populations Using PK-Sim

open access: yesFrontiers in Pharmacology, 2020
Physiologically based pharmacokinetic (PBPK) models are increasingly used to support pediatric dose selection for small molecule drugs. In contrast, only a few pediatric PBPK models for therapeutic antibodies have been published recently, and the ...
Sumit Basu   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy